Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Doxorubicin Hydrochloride and Epigallocatechin

Research Papers that Mention the Interaction

EGCG could sensitize the tumors to DOX as indicated by a considerable reduction of tumor weights.
The combination of DOX with EGCG increased the DOX concentration by 51% in the tumors, and increased DOX-induced apoptosis in the tumors compared with DOX alone.
Cancer letters  •  2004  |  View Paper
Resveratrol, epigallocatechin gallate, and tannic acid are polyphenolic compounds that were reported to have cardioprotective effect when combined with doxorubicin.
The combined use of epigallocatechin gallate or tannic acid with doxorubicin at a certain concentration could mitigate doxorubicin-induced keratinocyte cytotoxicity without weakening doxorubicin anticancer efficacy.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology  •  2018  |  View Paper
It seems that the presence of quercetin and EGCG in the diet may increase P-450 reductase activity during doxorubicin therapy with subsequent increased risk of toxicity.
Basic & clinical pharmacology & toxicology  •  2005  |  View Paper
EGCG modulated the function of P-gp and increased the intracellular accumulation of chemotherapeutic agent doxorubicin (DOX) in drug-resistant KB-A1 cells.
In KB-A1 cell xenograft model, EGCG could also enhance the efficacy of DOX and increased the DOX concentration in the resistant tumors.
In vitro EGCG potentiated the cytotoxicity of DOX to drug-resistant KB-A1 cells.
When KB-A1 cells were exposed to 10 microg/ml DOX combined with 10, 30, 50 microM EGCG for 4 h, the intracellular concentrations of DOX were increased 1.5, 1.9, 2.3 times, respectively compared with DOX alone treatment.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie  •  2005  |  View Paper
Tea polyphenol and (-)-epigallocatechin gallate enhanced the cytotoxicity of doxorubicin on KB-A-1 cells by 5.2 and 2.5 times, respectively, but did not show a modulating effect on KB-3-1 cells.
When 10 μg/ml (-)-epigallocatechin gallate or 40 μg/ml tea polyphenol were present simultaneously with doxorubicin , the IC50 of doxorubicin on KB-A-1 cells decreased from 10.3 ± 0.9 μg/ml to 4.2 ± 0.2 or 2.0 ± 0.1 μg/ml.
Journal of chemotherapy  •  2003  |  View Paper
This effect of doxorubicin was significantly suppressed by the antioxidants alpha-tocopherol, dexrazoxane, and epigallocatechin gallate.
Canadian journal of physiology and pharmacology  •  2010  |  View Paper
Components, such as caffeine, theanine, (-)-epigallocatechin gallate (EGCG) and flavonoids have inhibitory effects on the DOX efflux from Ehrlich ascites carcinoma cells.
Thus, it is suggested that EGCG and flavonoids may enhance DOX induced antitumor activity and increase the DOX concentrations in tumors through the inhibition of DOX efflux.
Toxicology letters  •  2000  |  View Paper